Skin antisepsis for reducing central venous catheter-related infections

Cochrane Database of Systematic Reviews

Volumn 2016, Issue 7, 2016, Pages

  Lai, Nai Ming ^a,b   Lai, Nai An ^c   O'Riordan, Elizabeth ^d   Chaiyakunapruk, Nathorn ^b,e,f   Taylor, Jacqueline E ^g   Tan, Kenneth ^h  

^a TAYLOR S UNIVERSITY   (Malaysia)

^b MONASH UNIVERSITY MALAYSIA   (Malaysia)

^c QUEEN ELIZABETH II JUBILEE HOSPITAL   (Australia)

^d CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^e NARESUAN UNIVERSITY   (Thailand)

^f UNIVERSITY OF QUEENSLAND   (Australia)

^g MONASH MEDICAL CENTRE   (Australia)

^h MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ANTIINFECTIVE AGENT; CHLORHEXIDINE; OCTENIDINE; POVIDONE IODINE; TOPICAL ANTIINFECTIVE AGENT;

ANTISEPSIS; AQUEOUS SOLUTION; BACTERIAL COLONIZATION; CATHETER INFECTION; CENTRAL VENOUS CATHETER; COMPARATIVE STUDY; DATA SYNTHESIS; DISEASE PREDISPOSITION; HUMAN; INJECTION SITE INFECTION; INTERVENTION STUDY; MORBIDITY; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PUBLICATION; QUALITY CONTROL; REVIEW; RISK ASSESSMENT; SENSITIVITY ANALYSIS; SEPTICEMIA; SYSTEMATIC REVIEW; THERAPY EFFECT; ADULT; ADVERSE EFFECTS; CATHETER-RELATED INFECTIONS; META ANALYSIS; MICROBIOLOGY; PROCEDURES; RANDOMIZED CONTROLLED TRIAL (TOPIC); SKIN;

ADULT; ANTI-INFECTIVE AGENTS, LOCAL; ANTISEPSIS; CATHETER-RELATED INFECTIONS; CENTRAL VENOUS CATHETERS; CHLORHEXIDINE; ETHANOL; HUMANS; POVIDONE-IODINE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SKIN;

EID: 84978811449     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD010140.pub2     Document Type: Review

References (142)

1. Dettenkofer M, Wilson C, Gratwohl A, Schmoor C, Bertz H, Frei R, et al. Skin disinfection with octenidine dihydrochloride for central venous catheter site care: a double-blind, randomized, controlled trial. Clinical Microbiology and Infection 2010; Vol. 6, issue 16:600-6.
2. Humar A, Ostromecki A, Direnfeld J, Marshall JC, Lazar N, Houston PC, et al. Prospective randomized trial of 10% povidone-iodine versus 0.5% tincture of chlorhexidine as cutaneous antisepsis for prevention of central venous catheter infection. Clinical Infectious Diseases 2000; Vol. 31, issue 4:1001-7.
3. Langgartner J, Linde HJ, Lehn N, Reng M, Schölmerich J, Glück T. Combined skin disinfection with chlorhexidine/propanol and aqueous povidone-iodine reduces bacterial colonisation of central venous catheters. Intensive Care Medicine 2004; Vol. 30, issue 6:1081-8.
4. Levy JH, Nagle DM, Curling PE, Waller JL, Kopel M, Tobia V. Contamination reduction during central venous catheterization. Critical Care Medicine 1988; Vol. 16, issue 2:165-7.
5. Maki DG, Ringer M, Alvarado CJ. Prospective randomised trial of povidone-iodine, alcohol, and chlorhexidine for prevention of infection associated with central venous and arterial catheters. The Lancet 1991; Vol. 338, issue 8763:339-43.
6. Maki DG, Ringer M, Alvarado CJ. Prospective randomized trial of povidone-iodine, alcohol, and chlorhexidine for prevention of infection associated with central venous and arterial catheters. CINA: Official Journal of the Canadian Intravenous Nurses Association 1993;9(1):10-15.
7. Mimoz O, Pieroni L, Lawrence C, Edouard A, Costa Y, Samii K, et al. Prospective, randomized trial of two antiseptic solutions for prevention of central venous or arterial catheter colonization and infection in intensive care unit patients. Critical Care Medicine 1996;24(11):1818-23.
8. Mimoz O, Pieroni L, Lawrence C, Edouard A, Samii K. Prospective trial of povidone-iodine (PI) and chlorhexidine (CH) for prevention of catheter-related sepsis (CRS). Proceedings of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy; 1994 Oct 4-7; Orlando (FL). 1994.
9. Mimoz O, Villeminey S, Ragot S, Dahyot-Fizelier C, Laksiri L, Petitpas F, et al. Chlorhexidine-based antiseptic solution vs alcohol-based povidone-iodine for central venous catheter care. Archives of Internal Medicine 2007; Vol. 167, issue 19:2066-72.
10. Prager RL, Silva J. Colonization of central venous catheters. Southern Medical Journal 1984; Vol. 77, issue 4:458-61.
11. Sadowski DA, Harrell DA, Maley MP, Warden GD. The value of culturing central-line catheter tips in burn patients. The Journal of Burn Care and Rehabilitation 1988;9(1):66-8.
12. Tuominen M, Valtonen VV, Nikki P. The effect of local antiseptic, chlorhexidine, in preventing infection from central venous catheterization: a clinical study. Annals of Clinical Research 1981; Vol. 13, issue 6:425-8.
13. Vallés J, Fernández I, Alcaraz D, Chacón E, Cazorla A, Canals M, et al. Prospective randomized trial of 3 antiseptic solutions for prevention of catheter colonization in an intensive care unit for adult patients. Infection Control and Hospital Epidemiology 2008; Vol. 29, issue 9:847-53.
14. Yasuda H, Sanui M, Fujitani S. Comparison of three cutaneous antiseptic solutions for the prevention of catheter colonization. Proceedings of the 43rd Critical Care Congress of the Society of Critical Care Medicine, SCCM 2014; 2014 Jan 9-13; San Francisco. Critical Care Medicine 2013;41(12 Suppl 1):A195.
15. Yasuda H, Sanui M, Komuro T, Hatakeyama J, Matsukubo S, Kawano S, et al. Comparison of three cutaneous antiseptic solutions for the prevention of catheter colonization in an ICU for adult patients: A multicenter prospective randomized controlled trial. Critical Care 2015;19(Suppl 1):73. [DOI: 10.1186/cc14153]
16. Yousefshahi F, Azimpour K, Boroumand MA, Najafi M, Barkhordari K, Vaezi M, et al. Can a new antiseptic agent reduce the bacterial colonization rate of central venous lines in post-cardiac surgery patients?. Journal of Tehran University Heart Center 2013;8(2):70-5.
17. Almeida M, Ferreira A, Reis P, Alves V, Dias C, Granja C. Reducing catheter-related bloodstream infections (CRBSI) in the ICU with an evidence-based intervention. Intensive Care Medicine 2009;35(Suppl 1):S271.
18. Apisarnthanarak A, Thongphubeth K, Yuekyen C, Warren DK, Fraser VJ. Effectiveness of a catheter-associated bloodstream infection bundle in a Thai tertiary care center: a 3-year study. American Journal of Infection Control 2010;38(6):449-55.
19. Assadian O. Skin antiseptic in reducing the risk of central venous catheter-related infections. Critical Care Medicine 2004;32(3):887-8.
20. Astle CM, Jensen L. A trial of ExSept for hemodialysis central venous catheters. Nephrology Nursing Journal 2005;32(5):517-25.
21. Balamongkhon B, Thamlikitkul V. Implementation of chlorhexidine gluconate for central venous catheter site care at Siriraj Hospital, Bangkok, Thailand. American Journal of Infection Control 2007;35(9):585-8.
22. Bilir A, Yelken B, Erkan A. Chlorhexidine, octenidine or povidone iodine for catheter related infections: a randomised controlled trial. Critical Care 2009; Vol. 13, issue Suppl 1:S79.
23. Borghesi A, Tzialla C, Decembrino L, Manzoni P, Stronati M. New possibilities of prevention of infection in the newborn. Journal of Maternal-Fetal and Neonatal Medicine 2011;24(Suppl 2):28-30.
24. Bowling G, Leykum L. Decreasing the rate of contaminated blood cultures. Proceedings of 2010 Annual Meeting of the Society of Hospital Medicine; 2010 Apr 8-11; Washington, DC. Journal of Hospital Medicine 2010;5(Suppl 1):85.
25. Camins BC, Richmond AM, Dyer KL, Zimmerman HN, Coyne DW, Rothstein M, et al. A crossover intervention trial evaluating the efficacy of a chlorhexidine-impregnated sponge in reducing catheter-related bloodstream infections among patients undergoing hemodialysis. Infection Control and Hospital Epidemiology 2010;31(11):1118-23.
26. Carrer S, Bocchi A, Bortolotti M, Braga N, Gilli G, Candini M, et al. Effect of different sterile barrier precautions and central venous catheter dressing on the skin colonization around the insertion site. Minerva Anestesiologica 2005;71(5):197-206.
27. Casey AL, Worthington T, Lambert PA, Quinn D, Faroqui MH, Elliott TS. A randomized, prospective clinical trial to assess the potential infection risk associated with the PosiFlow needleless connector. Journal of Hospital Infection 2003; Vol. 54, issue 4:288-93.
28. Casey AL, Burnell S, Whinn H, Worthington T, Faroqui MH, Elliott TS. A prospective clinical trial to evaluate the microbial barrier of a needleless connector. The Journal of Hospital Infection 2007;65(3):212-8.
29. Cepkova M, Matthay MA. Reducing risk in the ICU: vascular catheter-related infections. Infections in Medicine 2006;23(4):141-52.
30. Chaiyakunapruk N, Veenstra DL, Lipsky BA, Sullivan SD, Saint S. Vascular catheter site care: the clinical and economic benefits of chlorhexidine gluconate compared with povidone iodine. Clinical Infectious Diseases 2003;37(6):764-71.
31. Crawford AG, Fuhr JP, Rao B. Cost-benefit analysis of chlorhexidine gluconate dressing in the prevention of catheter-related bloodstream infections. Infection Control and Hospital Epidemiology 2004;25(8):668-74.
32. Daghistani D, Horn M, Rodriguez Z, Schoenike S, Toledano S. Prevention of indwelling central venous catheter sepsis. Medical and Pediatric Oncology 1996;26(6):405-8.
33. Darouiche RO. Preventing catheter-related infectious complications. Journal of Supportive Oncology 2007;5(2):70-1.
34. Darouiche RO. Prevention of infections associated with vascular catheters. International Journal of Artificial Organs 2008;31(9):810-9.
35. Dean R, Dillworth J, Phillips M. Assessment of daily bathing protocols: a comparison of chlorhexidine solution and chlorhexidine impregnated cloths. Proceedings of Critical Care Congress; 2012 Feb 4-8; Houston, TX. Critical Care Medicine 2011;39(Suppl 12):142.
36. Dettenkofer M, Jonas D, Wiechmann C, Rossner R, Frank U, Zentner J, et al. Effect of skin disinfection with octenidine dihydrochloride on insertion site colonization of intravascular catheters. Infection 2002; Vol. 30, issue 5:282-5.
37. Eggimann P, Joseph C, Thevenin MJ, Voirol P, Bellini C, Pagani JL, et al. Impact of chlorhexidine-impregnated sponges on catheter-related infections rate. Intensive Care Medicine 2010;36(Suppl 2):S128.
38. Eyberg CI, Pyrek J. A controlled randomized prospective comparative pilot study to evaluate the ease of use of a transparent chlorhexidine gluconate gel dressing versus a chlorhexidine gluconate disk in healthy volunteers. The Journal of the Association for Vascular Access 2008;13(3):112-7.
39. Freiberger D, Bryant J, Marino B. The effects of different central venous line dressing changes on bacterial growth in a pediatric oncology population. Journal of Pediatric Oncology Nursing 1992; Vol. 9, issue 3:3-7.
40. Fukunaga A, Naritaka H, Fukaya R, Tabuse M, Nakamura T. Povidone-iodine ointment and gauze dressings associated with reduced catheter-related infection in seriously ill neurosurgical patients. Infection Control and Hospital Epidemiology 2004; Vol. 25, issue 8:696-8.
41. Garcia J, Island E, McLaughlin G, Langshaw A, Socarra M, Lalanne J, et al. Prevention of central venous catheter infections using chlorhexidine: Scrub the Hub campaign in transplant patients. American Journal of Transplantation 2010;10(2):422-3.
42. Garcia-Teresa MA, Casado-Flores J, Delgado-Dominguez MA, Roqueta-Mas J, Cambra-Lasaosa F, Concha-Torre A, et al. Infectious complications of percutaneous central venous catheterization in pediatric patients: a Spanish multicenter study. Intensive Care Medicine 2007;33(3):466-76.
43. Garcia-Vazquez E, Murcia-Paya J, Canteras M, Gomez J. Influence of a hygiene promotion programme on infection control in an intensive-care unit. Clinical Microbiology and Infection 2011;17(6):894-900.
44. Garland JS, Alex CP, Mueller CD, Cisler-Kahill LA. Local reactions to a chlorhexidine gluconate-impregnated antimicrobial dressing in very low birth weight infants. The Pediatric Infectious Disease Journal 1996;15(10):912-4.
45. Garland JS, Alex CP, Mueller CD, Otten D, Shivpuri C, Harris MC, et al. A randomized trial comparing povidone-iodine to a chlorhexidine gluconate-impregnated dressing for prevention of central venous catheter infections in neonates. Pediatrics 2001;107(6):1431-6.
46. Garland JS, Alex CP, Uhing MR, Peterside IE, Rentz A, Harris MC. Pilot trial to compare tolerance of chlorhexidine gluconate to povidone-iodine antisepsis for central venous catheter placement in neonates. Journal of Perinatology 2009;29(12):808-13.
47. Garland JS, Harris MC, Uhing MR, Alex CP, Peterside I, Rentz A. Randomized pilot trial to assess safety of 2% chlorhexidine gluconate (CHG) in neonates with percutaneously placed central venous catheters (PICC). Proceedings of the Pediatric Academic Societies Annual Meeting; 2009 May 2-5; Baltimore, MD. 2009.
48. Jeffery S, Garland JS, Harris MC, Uhing MR, Alex CP, Peterside I, Rentz A. Randomized pilot trial to assess safety of 2% chlorhexidine gluconate (CHG) in neonates with percutaneously placed central venous catheters (PICC). Proceedings of the Pediatric Academic Societies Annual Meeting; 2009 May 2-5; Baltimore, MD. Baltimore: Pediatric Academic Societies, 2009.
49. Gilad J, Borer A. Prevention of catheter-related bloodstream infections in the neonatal intensive care setting. Expert Review of Anti-Infective Therapy 2006;4(5):861-73.
50. Girard R, Comby C, Jacques D. Alcoholic povidone-iodine or chlorhexidine-based antiseptic for the prevention of central venous catheter-related infections: in-use comparison. Journal of Infection and Public Health 2012;5(1):35-42.
51. Gnass SA, Barboza L, Bilicich D, Angeloro P, Treiyer W, Grenovero S, et al. Prevention of central venous catheter-related bloodstream infections using non-technologic strategies. Infection Control and Hospital Epidemiology 2004;25(8):675-7.
52. Gunst M, Matsushima K, Vanek S, Gunst R, Shafi S, Frankel H. Peripherally inserted central catheters may lower the incidence of catheter-related blood stream infections in patients in surgical intensive care units. Surgical Infections 2011;12(4):279-82.
53. Habibzadeh F, Yousefshahi F, Rouhipour N. Unethical conduct of underpowered clinical trials. Journal of Tehran University Heart Center 2013;8(4):213-4.
54. Hachem R, Raad I. Prevention and management of long-term catheter related infections in cancer patients. Cancer Investigation 2002;20(7-8):1105-13.
55. Halpin DP, O'Byrne P, McEntee G, Hennessy TP, Stephens RB. Effect of a betadine connection shield on central venous catheter sepsis. Nutrition 1991;7(1):33-4.
56. Hanazaki K, Shingu K, Adachi W, Miyazaki T, Amano J. Chlorhexidine dressing for reduction in microbial colonization of the skin with central venous catheters: a prospective randomized controlled trial. The Journal of Hospital Infection 1999;42(2):165-8.
57. Hill RL, Fisher AP, Ware RJ, Wilson S, Casewell MW. Mupirocin for the reduction of colonization of internal jugular cannulae: a randomized controlled trial. The Journal of Hospital Infection 1990;15(4):311-21.
58. Huang SS, Yokoe DS, Hinrichsen VL, Spurchise LS, Datta R, Miroshnik I, et al. Impact of routine intensive care unit surveillance cultures and resultant barrier precautions on hospital-wide methicillin-resistant Staphylococcus aureus bacteremia. Clinical Infectious Diseases 2006;43(8):971-8.
59. Hutchinson SK, Waskerwitz M, Martin K, Faubion W, Revesz S. Nonocclusive, clean permanent right atrial catheter dressing change procedures compared with occlusive, sterile permanent right atrial catheter dressing change procedures in children with cancer. Journal of Pediatric Oncology Nursing 1990;7(2):71.
60. Ishikawa Y, Kiyama T, Haga Y, Ishikawa M, Takeuchi H, Kimura O, et al. Maximal sterile barrier precautions do not reduce catheter-related bloodstream infections in general surgery units: a multi-institutional randomized controlled trial. Annals of Surgery 2010;251(4):620-3.
61. Ishizuka M, Nagata H, Takagi K, Kubota K. Comparison of 0.05% chlorhexidine and 10% povidone-iodine as cutaneous disinfectant for prevention of central venous catheter-related bloodstream infection: a comparative study. European Surgical Research 2009;43(3):286-90.
62. Johnson DW, Van Eps C, Mudge DW, Wiggins KJ, Armstrong K, Hawley CM, et al. Randomized, controlled trial of topical exit-site application of honey (Medihoney) versus mupirocin for the prevention of catheter-associated infections in hemodialysis patients. Journal of the American Society of Nephrology 2005;16(5):1456-62.
63. Khattak AZ, Ross R, Ngo T, Shoemaker CT. A randomized controlled evaluation of absorption of silver with the use of silver alginate (Algidex) patches in very low birth weight (VLBW) infants with central lines. Journal of Perinatology 2010;30(5):337-42.
64. Khouli HI, Jahnes K, Mathew J, Gohil A, Shapiro J, Rose K, et al. Medical residents' performance in maximum barrier precautions during central venous catheter placement: effect of simulation-based training. Chest 2009;136(4):12S.
65. Krein SL, Hofer TP, Kowalski CP, Olmsted RN, Kauffman CA, Forman JH, et al. Use of central venous catheter-related bloodstream infection prevention practices by US hospitals. Mayo Clinic Proceedings 2007;82(6):672-8.
66. Kruse JA. Chlorhexidina gluconate solution prevented catheter colonization and infection [La solucion de gluconato de clorhexidina previene la colonizacion e infeccion del cateter]. Enfermedades Infecciosas y Microbiologia Clinica 1999;19(1):37-8.
67. Kulkarni AP, Awode M. A prospective randomised trial to compare the efficacy of povidone-iodine 10% and chlorhexidine 2% for skin disinfection. Indian Journal of Anaesthesia 2013;57(3):270-5.
68. Lange BJ, Weiman M, Feuer EJ, Jakobowski D, Bilodeau J, Stallings VA, et al. Impact of changes in catheter management of infectious complications among children with central venous catheters. Infection Control and Hospital Epidemiology 1997;18(5):326-32.
69. Le Corre I, Delorme M, Cournoyer S. A prospective, randomized trial comparing a transparent dressing and a dry gauze on the exit site of long term central venous catheters of hemodialysis patients. Journal of Vascular Access 2003;4(2):56-61.
70. Legras A, Cattier B, Dequin PF, Boulain T, Perrotin D. Prospective randomised trial for prevention of vascular-catheter infection: Alcohol chlorhexidine versus povidone-iodine. [Etude prospective randomisée pour la prévention des infections liées aux cathéters: chlorhexidine alcoolique contre polyvidone iodée]. Réanimation Urgences 1997; Vol. 6, issue 1:5-11.
71. Levy I, Katz J, Solter E, Samra Z, Vidne B, Birk E, et al. Chlorhexidine-impregnated dressing for prevention of colonization of central venous catheters in infants and children: a randomized controlled study. The Pediatric Infectious Disease Journal 2005;24(8):676-9.
72. Madeo M, Martin CR, Turner C, Kirkby V, Thompson DR. A randomized trial comparing Arglaes (a transparent dressing containing silver ions) to Tegaderm (a transparent polyurethane dressing) for dressing peripheral arterial catheters and central vascular catheters. Intensive and Critical Care Nursing 1998;14(4):187-91.
73. Mahieu LM, De Dooy JJ, Lenaerts AE, Leven MM, De Muynck AO. Catheter manipulations and the risk of catheter-associated bloodstream infection in neonatal intensive care unit patients. Journal of Hospital Infection 2001;48(1):20-6.
74. Maki DG, Band JD. A comparative study of polyantibiotic and iodophor ointments in prevention of vascular catheter-related infection. The American Journal of Medicine 1981;3:739-44.
75. Maki D. Choosing a disinfectant for central catheters. Nursing Times 1992;12:54-5.
76. McCann M, Fitzpatrick F, Mellotte G, Clarke M. Is 2% chlorhexidine gluconate in 70% isopropyl alcohol more effective at preventing central venous catheter-related infections than routinely used chlorhexidine gluconate solutions: a pilot multicenter randomized trial (ISRCTN2657745)?. American Journal of Infection Control 2016:Epub ahead of print.
77. Montecalvo MA, McKenna D, Yarrish R, Mack L, Maguire G, Haas J, et al. Chlorhexidine bathing to reduce central venous catheter-associated bloodstream infection: impact and sustainability. American Journal of Medicine 2012;125(5):505-11.
78. Munoz-Price LS, Hota B, Stemer A, Weinstein RA. Prevention of bloodstream infections by use of daily chlorhexidine baths for patients at a long-term acute care hospital. Infection Control and Hospital Epidemiology 2009;30(11):1031-5.
79. Munoz-Price LS, Dezfulian C, Wyckoff M, Lenchus JD, Rosalsky M, Birnbach DJ, et al. Effectiveness of stepwise interventions targeted to decrease central catheter-associated bloodstream infections. Critical Care Medicine 2012;40(5):1464-9.
80. Nikoletti S, Leslie G, Gandossi S, Coombs G, Wilson R. A prospective, randomized, controlled trial comparing transparent polyurethane and hydrocolloid dressings for central venous catheters. American Journal of Infection Control 1999;27(6):488-96.
81. Noto M, Domenico H, Talbot T, Byrne D, Wheeler A. Healthcare-associated infections and chlorhexidine bathing: a pragmatic cluster-randomized trial. Proceedings of the 2015 Critical Care Congress 2015; 2015 Jan 17-21; Phoenix, AZ. Critical Care Medicine 2014;42(12 Suppl 1):A1478-9.
82. Parienti JJ, Du Cheyron D, Ramakers M, Malbruny B, Leclercq R, Le Coutour X, et al. Alcoholic povidone-iodine to prevent central venous catheter colonization: A randomized unit-crossover study. Critical Care Medicine 2004;32(3):708-13.
83. Peterson K. Central venous catheter injection cap disinfection: chlorhexidine versus 70% alcohol. Journal of Pediatric Nursing 2011;26(2):e6.
84. Raad II, Hohn DC, Gilbreath BJ, Suleiman N, Hill LA, Bruso PA, et al. Prevention of central venous catheter-related infections by using maximal sterile barrier precautions during insertion. Infection Control and Hospital Epidemiology 1994;15(4 Pt 1):231-8.
85. Render ML, Brungs S, Kotagal U, Nicholson M, Burns P, Ellis D, et al. Evidence-based practice to reduce central line infections. Joint Commission Journal on Quality and Patient Safety 2006;32(5):253-60.
86. Rezaei J, Esfandiari Kh, Tavakoli H, Sadooghi M, Hasibi M, Behzadi M. Evaluation of mupirocin ointment in control of central venous catheter related infections: a randomized clinical trial. Tehran University Medical Journal 2009;67(6):428-34.
87. Richardson D. Literature review [Alcoholic povidone-iodine to prevent central venous catheter colonization: a randomized unit-crossover study]. Journal of the Association for Vascular Access 2006;11(2):76.
88. Rickard CM, Lipman J, Courtney M, Siversen R, Daley P. Routine changing of intravenous administration sets does not reduce colonization or infection in central venous catheters. Infection Control and Hospital Epidemiology 2004;25(8):650-5.
89. Rijnders BJ, Van Wijngaerden E, Wilmer A, Peetermans WE. Use of full sterile barrier precautions during insertion of arterial catheters: a randomized trial. Clinical Infectious Diseases 2003;36(6):743-8.
90. Rubinson L, Diette GB. Best practices for insertion of central venous catheters in intensive-care units to prevent catheter-related bloodstream infections. Journal of Laboratory and Clinical Medicine 2004;143(1):5-13.
91. Rupp ME, Fitzgerald T, Puumala S, Anderson JR, Craig R, Iwen PC, et al. Prospective, controlled, cross-over trial of alcohol-based hand gel in critical care units. Infection Control and Hospital Epidemiology 2008;29(1):8-15.
92. Ruschulte H, Franke M, Gastmeier P, Zenz S, Mahr KH, Buchholz S, et al. Prevention of central venous catheter related infections with chlorhexidine gluconate impregnated wound dressings: a randomized controlled trial. Annals of Hematology 2009; Vol. 88, issue 3:267-72.
93. Schwebel C, Lucet JC, Vesin A, Arrault X, Calvino-Gunther S, Bouadma L, et al. Economic evaluation of chlorhexidine-impregnated sponges for preventing catheter-related infections in critically ill adults in the Dressing Study. Critical Care Medicine 2012;40(1):11-17.
94. Sheehan G, Leicht K, O'Brien M, Taylor G, Rennie R. Chlorhexidine versus povidone-iodine as cutaneous antisepsis for prevention of vascular-catheter infection. Proceedings of the 33rd Interscience Conference on Antimicrobial Agents and Chemotherapy; 1993 Oct 17-20; New Orleans, LA. 1993:a1616.
95. Spiegler P. Comparing central line and arterial line infections. Clinical Pulmonary Medicine 2010;17(5):248-9.
96. Swan J, Bui L, Pham V, Shirkey B, Graviss E, Hai S, et al. RCT Of chlorhexidine vs. soap & water bathing for prevention of hospital-acquired infections in SICU. Proceedings of the 2015 Critical Care Congress; 2015 Jan 17-21; Phoenix, AZ. Critical Care Medicine 2014;42(12 Suppl 1):A1369-70.
97. Tietz A, Frei R, Dangel M, Bolliger D, Passweg JR, Gratwohl A, et al. Octenidine hydrochloride for the care of central venous catheter insertion sites in severely immunocompromised patients. Infection Control and Hospital Epidemiology 2005;26(8):703-7.
98. Van Esch J. Chlorhexidine reduced catheter tip colonisation more than 10% povidone-iodine in critically ill neonates. Evidence-Based Nursing 2002;5(3):73.
99. Zingg W, Cartier-Fassler V, Walder B. Central venous catheter-associated infections. Best Practice and Research: Clinical Anaesthesiology 2008;22(3):407-21.
100. Zingg W, Imhof A, Maggiorini M, Stocker R, Keller E, Ruef C. Impact of a prevention strategy targeting hand hygiene and catheter care on the incidence of catheter-related bloodstream infections. Critical Care Medicine 2009;37(7):2167-73.
101. Atahan K, Cokmez A, Bekoglu M, Durak E, Tavusbay C, Tarcan E. The effect of antiseptic solution in central venous catheter care. Bratislavske Lekarske Listy 2012;113(9):548-51.
102. Bilir A, Yelken B, Erkan A. Chlorhexidine, octenidine or povidone iodine for catheter related infections: a randomised controlled trial. Journal of Research in Medical Sciences 2013;18(6):510-2.
103. Giles Y, Aksoy M, Tezelman S. What really affects the incidence of central venous catheter-related infections for short-term catheterization?. Acta Chirurgica Belgica 2002;102(4):256-8.
104. Knasinski V, Maki DG. A prospective, randomized, controlled trial of 1% chlorhexidine 75% alcohol vs. 10% povidone iodine for cutaneous disinfection and follow-up site care with central venous and arterial catheters. Proceedings of the National Association of Vascular Access Network Conference; 2000 September 6-10; San Diego, CA. San Diego, 2000.
105. Mimoz O, Lucet JC, Kerforne T, Pascal J, Souweine B, Goudet V, et al. Skin antisepsis with chlorhexidine-alcohol versus povidone iodine-alcohol, with and without skin scrubbing, for prevention of intravascular-catheter-related infection (CLEAN): an open-label, multicentre, randomised, controlled, two-by-two factorial trial. Lancet 2015;386(10008):2069-2077. [DOI: 10.1016/S0140-6736]
106. Yamamoto N, Kimura H, Misao H, Matsumoto H, Imafuku Y, Watanabe A, et al. Efficacy of 1.0% chlorhexidine-gluconate ethanol compared with 10% povidone-iodine for long-term central venous catheter care in hematology departments: a prospective study. American Journal of Infection Control 2014;42(5):574-6.
107. Goudet V, Timsit JF, Lucet JC, Lepape A, Balayn D, Seguin S, et al. Comparison of four skin preparation strategies to prevent catheter-related infection in intensive care unit (CLEAN trial): a study protocol for a randomized controlled trial. Trials 2013;14:114.
108. Adams D, Elliot TS. Skin antiseptics used prior to intravascular catheter insertion. British Journal of Nursing 2007;16(5):278-80.
109. Bankston J. Joseph Lister and the History of Antiseptics. Hockessin: Mitchell Lane Publishers, 2005.
110. Bynum W. The History of Medicine: A Very Short Introduction. New York: Oxford University Press, 2008.
111. Campbell MK, Mollison J, Grimshaw JM. Cluster trials in implementation research: estimation of intracluster correlation coefficients and sample size. Statistics in Medicine 2001;20(3):391-9.
112. Centers for Disease Control and Prevention (CDC). Guidelines for the prevention of intravascular catheter-related infections, 2011. http://www.cdc.gov/hicpac/BSI/BSI-guidelines-2011.html (accessed 4 June 2015).
113. Chaiyakunapruk N, Veenstra DL, Lipsky BA, Saint S. Chlorhexidine compared with povidone-iodine solution for vascular catheter-site care: a meta-analysis. Annals of Internal Medicine 2002;136(11):792-801.
114. Cicalini S, Palmieri F, Petrosillo N. Clinical review: new technologies for prevention of intravascular catheter-related infections. Critical Care 2004;8(3):157-62.
115. Edwards JR, Peterson KD, Andrus ML, Dudeck MA, Pollock DA, Horan TC. National Healthcare Safety Network (NHSN) Report, data summary for 2006 through 2007, issued November 2008. American Journal of Infection Control 2008;36(9):609-26.
116. Guyatt GH, Sackett DL, Cook DJ, Evidence-Based Medicine Working Group. Users' guides to the medical literature II. How to use an article about therapy or prevention A. Are the results of the study valid?. JAMA 1993;270(21):2598-601.
117. Hamilton HC, Foxcroft DR. Central venous access sites for the prevention of venous thrombosis, stenosis and infection in patients requiring long-term intravenous therapy. Cochrane Database of Systematic Reviews 2007, Issue 3. [DOI: 10.1002/14651858.CD004084.pub2]
118. Hardin W, Nichols R. Handwashing and patient skin preparation. In: Malangoni MA editor(s). Critical Issues in Operating Room Management. Philadelphia: Lippincott-Raven, 1997:133-49.
119. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. British Medical Journal 2003;327:557-60.
120. Higgins JPT, Altman DG, Sterne JAC. Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook of Systematic Reviews of Interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
121. Higgins JPT, Deeks J, Altman DG. Chapter 16: Special topics in statistics. In: Higgins JPT, Green S (editors). Cochrane Handbook of Systematic Reviews of Interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
122. Larson EL. APIC guideline for handwashing and hand antisepsis in health care settings. American Journal of Infection Control 1995;23(4):251-69.
123. Lefebvre C, Manheimer E, Glanville J. Chapter 6: Searching for studies. In: Higgins JPT, Green S (editors). Cochrane Handbook of Systematic Reviews of Interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
124. Brayfield, A (editor). Martindale: the complete drug reference. www.medicinescomplete.com/mc/martindale/current/ (accessed 6 July 2016).
125. McCann M, Moore ZEH. Interventions for preventing infectious complications in haemodialysis patients with central venous catheters. Cochrane Database of Systematic Reviews 2010, Issue 1. [DOI: 10.1002/14651858.CD006894.pub2]
126. US Department of Health and Human Services. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. American Journal of Infection Control 2004;32(8):470-85.
127. Nuland SB. The Doctors' Plague: Germs, Childbed Fever and the Strange Story of Ignaz Semmelweis. New York: WW Norton, 2003.
128. O'Grady NP, Alexander M, Dellinger EP, Gerberding JL, Heard SO, Maki DG, et al. Guidelines for the prevention of intravascular catheter-related infections. Centers for Disease Control and Prevention. Morbidity and Mortality Weekly Report (MMWR) 2002; Vol. 51, issue RR-10:1-29.
129. Pagani JL, Eggimann P. Management of catheter-related infection. Expert Review of Anti-infective Therapy 2008;6(1):31-7.
130. Pratt RJ, Pellowe CM, Wilson JA, Loveday HP, Harper PJ, Jones SR, et al. epic2: National evidence-based guidelines for preventing healthcare-associated infections in NHS hospitals in England. Journal of Hospital Infection 2007;65(Suppl 1):S1-64.
131. Puri N, Puri V, Dellinger RP. History of technology in the intensive care unit. Critical Care Clinics 2009;25(1):185-200, ix.
132. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
133. Russell AD. Chlorhexidine: antibacterial action and bacterial resistance. Infection 1986;14(5):212-5.
134. Ryan KJ, Ray G (editors). Sherris Medical Microbiology. 4th Edition. New York: McGraw-Hill, 2004.
135. Schünemann HJ, Oxman AD, Higgins JPT, Vist GE, Glasziou P, Guyatt GH. Chapter 11: Presenting results and 'Summary of findings' tables. In: Higgins JPT, Green S (editors). Cochrane Handbook of Systematic Reviews of Interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
136. Schünemann HJ, Oxman AD, Vist GE, Higgins JPT, Deeks JJ, Glasziou P, et al. Chapter 12: Interpreting results and drawing conclusions. In: Higgins JPT, Green S (editors). Cochrane Handbook of Systematic Reviews of Interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
137. Scottish Intercollegiate Guidelines Network (SIGN). Search filters. http:www.sign.ac.uk/methodology/filters.html#random (accessed 4 June 2015).
138. Sterne JAC, Egger M, Moher D (editors). Chapter 10: Addressing reporting biases. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Intervention. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
139. Venes D (editor). Taber's Cyclopedic Medical Dictionary Online. http://www.tabers.com/tabersonline/view/Tabers-Dictionary/738695/0/antiseptic?q=antiseptic&ti=0 (accessed 6 July 2016).
140. Trieschmann U, Cate UT, Sreeram N. Central venous catheters in children and neonates - what is important?. Images in Paediatric Cardiology 2007;9(4):1-8. [PUBMED: 22368674]
141. Worthington T, Elliott TS. Diagnosis of central venous catheter related infection in adult patients. Journal of Infection 2005;51(4):267-80.
142. Lai NA, Lai NM, O'Riordan E, Chaiyakunapruk N, Taylor JE, Tan K. Skin antisepsis during catheter insertion for reducing central venous catheter related infections. Cochrane Database of Systematic Reviews 2012, Issue 10. [DOI: 10.1002/14651858.CD010140]